Literature DB >> 19955324

Antibodies against structural and nonstructural proteins of human bocavirus in human sera.

Reza Shirkoohi1, Rika Endo, Nobuhisa Ishiguro, Shinobu Teramoto, Hideaki Kikuta, Tadashi Ariga.   

Abstract

Immunofluorescence assays (IFAs) for detection of human bocavirus (HBoV) proteins (VP1, VP2, NP-1, and NS1) were developed. The VP1 IFA was the most sensitive for detection of IgG antibody and suitable for screening. IgG antibodies in convalescent-phase sera from HBoV-positive patients were detected by VP1 and VP2 IFAs. Sensitivities of NP-1 and NS1 IFAs were low.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19955324      PMCID： PMC2812099          DOI： 10.1128/CVI.00355-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  43 in total

1.  Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino-terminal half of the unique region of VP1.

Authors:  M Musiani; E Manaresi; G Gallinella; S Venturoli; E Zuffi; M Zerbini
Journal:  J Med Virol       Date:  2000-03       Impact factor: 2.327

2.  Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection.

Authors:  J R Kerr; V S Cunniffe
Journal:  Rheumatology (Oxford)       Date:  2000-08       Impact factor: 7.580

3.  Real-time PCR assays for detection of bocavirus in human specimens.

Authors:  Xiaoyan Lu; Malinee Chittaganpitch; Sonja J Olsen; Ian M Mackay; Theo P Sloots; Alicia M Fry; Dean D Erdman
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

4.  Human bocavirus in Italian patients with respiratory diseases.

Authors:  Fabrizio Maggi; Elisabetta Andreoli; Massimo Pifferi; Silvia Meschi; Jara Rocchi; Mauro Bendinelli
Journal:  J Clin Virol       Date:  2007-03-01       Impact factor: 3.168

Review 5.  Human bocavirus: passenger or pathogen in acute respiratory tract infections?

Authors:  Oliver Schildgen; Andreas Müller; Tobias Allander; Ian M Mackay; Sebastian Völz; Bernd Kupfer; Arne Simon
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

6.  Seroepidemiology of human bocavirus in Hokkaido prefecture, Japan.

Authors:  Rika Endo; Nobuhisa Ishiguro; Hideaki Kikuta; Shinobu Teramoto; Reza Shirkoohi; Xiaoming Ma; Takashi Ebihara; Hiroaki Ishiko; Tadashi Ariga
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

7.  Evidence of prior exposure to human bocavirus as determined by a retrospective serological study of 404 serum samples from adults in the United States.

Authors:  Sylvain Cecchini; Alejandro Negrete; Tamas Virag; Barney S Graham; Jeffrey I Cohen; Robert M Kotin
Journal:  Clin Vaccine Immunol       Date:  2009-02-25

8.  Human bocavirus in French children.

Authors:  Vincent Foulongne; Yann Olejnik; Virginie Perez; Stéphane Elaerts; Michel Rodière; Michel Segondy
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

9.  The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005.

Authors:  Eun Hwa Choi; Hoan Jong Lee; Sun Jung Kim; Byung Wook Eun; Nam Hee Kim; Jin A Lee; Jun Ho Lee; Eun Kyung Song; So Hee Kim; Ji Yong Park; Ji Yeon Sung
Journal:  Clin Infect Dis       Date:  2006-07-26       Impact factor: 9.079

10.  Human bocavirus and acute wheezing in children.

Authors:  Tobias Allander; Tuomas Jartti; Shawon Gupta; Hubert G M Niesters; Pasi Lehtinen; Riikka Osterback; Tytti Vuorinen; Matti Waris; Annelie Bjerkner; Annika Tiveljung-Lindell; Bernadette G van den Hoogen; Timo Hyypiä; Olli Ruuskanen
Journal:  Clin Infect Dis       Date:  2007-02-14       Impact factor: 9.079
View more
  1 in total

1.  Human bocavirus amongst an all-ages population hospitalised with acute lower respiratory infections in Cambodia.

Authors:  Alicia Arnott; Sirenda Vong; Sareth Rith; Monica Naughtin; Sowath Ly; Bertrand Guillard; Vincent Deubel; Philippe Buchy
Journal:  Influenza Other Respir Viruses       Date:  2012-04-25       Impact factor: 4.380
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.